Moderna stock hits all-time high with new vaccine project

The biotechnology sector took center stage, with shares of Moderna and Novavax soaring due to new advancements in vaccines, while Apple felt the pressure from reports of reduced orders for the iPhone 18 Pro.

What moved the market

1. Moderna shines with new cancer vaccine

   The market reacted positively to the news of Moderna's plan to develop a national cancer vaccine, bringing its shares to a level not seen in four years. This movement rekindles optimism in innovations within the healthcare sector, which promises to revolutionize treatments and attract investments.

   AffectsMRNA+14.21%

2. Novavax stands out in the vaccine race

   Novavax saw its shares rise dramatically, in tune with Moderna's momentum. The company continues to be a significant player in biotechnology, with increasing expectations regarding new vaccines, signaling a phase of potential market expansion.

   AffectsNVAX+15.80%

4. Apple struggles with declines following demand report

   Apple faced a challenging day, with its shares falling after a report indicated that the company was reducing component orders due to weak demand for the new iPhone 18 Pro. This raises concerns about the company's performance in an increasingly competitive market.

   AffectsAAPL-1.11%

5. Netflix faces uncertainties following news of layoffs

   The day was complicated for Netflix, which saw its shares drop amid rumors of significant layoffs. Such news typically generates uncertainty about the company's future direction and its ability to remain competitive, which can affect investor confidence in the short term.

   AffectsNFLX-1.77%

6. # Amazon Benefits from New AI Contracts

   Amazon also had a positive performance, driven by $50 million investments in artificial intelligence. This move not only strengthens its position in the sector, but can also open doors for more innovations and strategic partnerships.

   AffectsAMZN+3.29%